Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

5.7%

2 terminated/withdrawn out of 35 trials

Success Rate

92.0%

+5.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

22%

5 of 23 completed trials have results

Key Signals

5 recruiting5 with results

Enrollment Performance

Analytics

Phase 1
16(47.1%)
N/A
10(29.4%)
Phase 2
6(17.6%)
Early Phase 1
2(5.9%)
34Total
Phase 1(16)
N/A(10)
Phase 2(6)
Early Phase 1(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (35)

Showing 20 of 35 trials
NCT07171554Not ApplicableRecruiting

Evaluation of a Diagnostic Test to Identify the Best Drugs for Treatment of Metastatic Colorectal Cancer

Role: collaborator

NCT06118684Phase 1Completed

Clinical Trial to Assess Effect of Verapamil on Systemic Exposure of EP395 and Effect of EP395 on Systemic Exposure of Midazolam and Digoxin

Role: collaborator

NCT07069725Phase 1Recruiting

The Phase 1, Open-label, PET Trial Designed to Investigate the Effect of AZD2389 on FAP Occupancy in the Liver in Participants With Advanced Liver Fibrosis.

Role: collaborator

NCT07394777Not ApplicableCompleted

An Open Single-armed Investigation to Evaluate the Safety of pHyph Following a Prolonged Treatment Duration in Adult Women With Bacterial Vaginosis

Role: collaborator

NCT07405853Not ApplicableRecruiting

An Investigation to Evaluate the Clinical Performance and Safety of pHyph in Adult Women With Vulvovaginal Candidiasis Compared With an Untreated Control Group

Role: collaborator

NCT06989645Phase 1Completed

A Phase 1/2a Study to Evaluate Single Intraarticular Injections of 3 Dose Levels of SYN321 and Placebo in Patients With Symptomatic Knee Osteoarthritis

Role: collaborator

NCT06888362Phase 1Completed

Trial to Investigate GZ21T in Healthy Volunteers

Role: collaborator

NCT06463275Completed

SpinChip Hs-cTnI Determination of the 99th Percentile URL

Role: collaborator

NCT07204691Not ApplicableNot Yet Recruiting

A Study to Evaluate the Safety and Performance of Dr Korman Laboratories' Hyaluronic Acid Filler 20 mg/mL With Lidocaine for Lip Augmentation

Role: collaborator

NCT06611423Phase 1Terminated

AZD3427 Effects on Renal Perfusion in Heart Failure Patients With Reduced Ejection Fraction and Renal Impairment

Role: collaborator

NCT05512234Not ApplicableRecruiting

Effect of Probiotic Limosilactobacillus Reuteri (L. Reuteri) on Crying Time in Infants With Colic

Role: collaborator

NCT05629091Not ApplicableTerminated

An Investigation of Performance and Safety of the Wound Dressing FibDex in Patients With Superficial Dermal Burns

Role: collaborator

NCT05908643Phase 1Recruiting

A First-In-Human Trial of pTTL in Advanced Colorectal Cancer

Role: collaborator

NCT05277922Phase 1Completed

Effect of C21 on Forearm Blood Flow

Role: collaborator

NCT06797427Early Phase 1Completed

A Study to Assess the Pharmacokinetics of Sorafenib in Mesoporous Magnesium Carbonate (DPH001) Compared to Nexavar® (sorafenib) in Healthy Volunteers

Role: collaborator

NCT06360640Phase 1Completed

A First-in-human Trial to Evaluate Safety, Tolerability, and Pharmacokinetics of APC148 in Healthy Adults

Role: collaborator

NCT06782724Phase 2Not Yet Recruiting

Psilocybin Therapy for Psychological Distress in Palliative Patients

Role: collaborator

NCT05246618Phase 1Completed

FIH Phase I/IIa Trial Evaluating Safety of TUM012 to Minimize Ischemic Reperfusion Injury in Kidney Transplantation

Role: collaborator

NCT05148884Phase 2Completed

Study to Assess the Safety, Tolerability and Preliminary Efficacy of NLX-112 Versus Placebo in L-dopa-induced Dyskinesia

Role: collaborator

NCT05934110Phase 2Active Not Recruiting

Study Exploring the Supportive Effect of Acarbose in Weight Management

Role: collaborator